Goldman Sachs’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.4K | Buy |
+17,529
| New | +$24.4K | ﹤0.01% | 5032 |
|
|
2025
Q1 | – | Sell |
-110,906
| Closed | -$145K | – | 5236 |
|
|
2024
Q4 | $145K | Buy |
+110,906
| New | +$145K | ﹤0.01% | 4714 |
|
|
2024
Q3 | – | Sell |
-20,169
| Closed | -$66.6K | – | 4978 |
|
|
2024
Q2 | $66.6K | Sell |
20,169
-16,118
| -44% | -$53.2K | ﹤0.01% | 4538 |
|
|
2024
Q1 | $171K | Buy |
36,287
+7,349
| +25% | +$34.6K | ﹤0.01% | 4365 |
|
|
2023
Q4 | $211K | Sell |
28,938
-35,409
| -55% | -$258K | ﹤0.01% | 4305 |
|
|
2023
Q3 | $777K | Sell |
64,347
-671
| -1% | -$8.11K | ﹤0.01% | 3668 |
|
|
2023
Q2 | $688K | Sell |
65,018
-11,993
| -16% | -$127K | ﹤0.01% | 3813 |
|
|
2023
Q1 | $758K | Buy |
77,011
+12,567
| +20% | +$124K | ﹤0.01% | 3852 |
|
|
2022
Q4 | $948K | Buy |
64,444
+15,134
| +31% | +$223K | ﹤0.01% | 3726 |
|
|
2022
Q3 | $598K | Sell |
49,310
-765
| -2% | -$9.28K | ﹤0.01% | 4131 |
|
|
2022
Q2 | $700K | Buy |
50,075
+8,330
| +20% | +$116K | ﹤0.01% | 4171 |
|
|
2022
Q1 | $594K | Buy |
41,745
+10,649
| +34% | +$152K | ﹤0.01% | 4461 |
|
|
2021
Q4 | $656K | Sell |
31,096
-9,061
| -23% | -$191K | ﹤0.01% | 4342 |
|
|
2021
Q3 | $1.05M | Sell |
40,157
-26,461
| -40% | -$695K | ﹤0.01% | 3932 |
|
|
2021
Q2 | $2.08M | Buy |
66,618
+12,248
| +23% | +$382K | ﹤0.01% | 3476 |
|
|
2021
Q1 | $1.67M | Buy |
54,370
+36,487
| +204% | +$1.12M | ﹤0.01% | 3524 |
|
|
2020
Q4 | $613K | Buy |
+17,883
| New | +$613K | ﹤0.01% | 3718 |
|
|
2020
Q3 | – | Sell |
-12,353
| Closed | -$383K | – | 4547 |
|
|
2020
Q2 | $383K | Buy |
+12,353
| New | +$383K | ﹤0.01% | 3720 |
|